-
Viesearch·
-
@ramkumareditor·
Ornithine-Transcarbamylase Deficiency Market Analysis
The Ornithine-Transcarbamylase deficiency market is projected to reach USD 896.6 million by 2028, growing at a CAGR of 3.4%. The deficiency causes ammonia buildup in the blood.